Anixa Biosciences announced that a patient in their Phase 1 trial of liraltagene autoleucel (lira-cel), a CAR-T therapy targeting ovarian cancer, exhibited stable disease 90 days after treatment, marking the first such response in the trial. Multiple patients have survived over a year, including one beyond two years, with no dose-limiting toxicities observed so far. The therapy targets the follicle-stimulating hormone receptor (FSHR) on ovarian cancer cells and is being tested for safety and preliminary efficacy. The company and Moffitt Cancer Center will continue dose escalation to evaluate further responses and safety.
Anixa Biosciences' ovarian cancer CAR-T trial is the subject, with Pluang's health sector data providing market context. Of 100 priced US health stocks on Pluang, 41 rose and 41 fell today. Notable movers include TXG at USD 94.72 (+1.30%), ZBH at USD 89.44 (+1.30%), and RVTY at USD 153.50 (+1.30%), as of Oct 05, 2026 18:12 WIB.
Oppenheimer has maintained its Outperform rating on Enphase Energy but lowered the price target from $56 to $55. Enphase Energy, a company specializing in solar microinverters, home batteries, and energy management products, has seen its shares drop ...
UBS increased its price target for Ball Corp. from $65 to $66, citing steady demand for packaging products and growth in South America. The stock currently trades at $56.37, implying a potential 17.1% upside. Key factors supporting investor interest ...
Datasea Intelligent Technology reported a 57% reduction in net loss to $2.19 million for fiscal 2026, alongside a positive operating cash flow of $1.98 million, marking significant financial improvement despite a 43% revenue drop to $40.7 million. Th...
Tokyo-listed Metaplanet sold 10,000 BTC and later repurchased 11,000 BTC in Q3 2026 to demonstrate to credit rating agencies and bond investors its ability to convert bitcoin into cash. This round trip transaction left it holding 44,000 BTC and raise...
U.S. bitcoin ETFs attracted $241.08 million in inflows for the week ending Oct. 2, marking their third consecutive week of positive net inflows despite a 90% slowdown from the previous period. Blackrock's bitcoin ETF led with $450 million in net infl...
